Hrustanovic Gorjan
SEC insider (Form 3/4/5 filer). CIK 0001821194. Director at Kymera Therapeutics, Inc. (KYMR) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in SAN FRANCISCO, CA.
Companies Hrustanovic Gorjan has filed insider reports for
- Kymera Therapeutics, Inc. (KYMR): Director
- Olema Pharmaceuticals, Inc. (OLMA): Director
Hrustanovic Gorjan
CIK: 0001821194
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 24, 2026KYMR
Kymera Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
6.1K shares- - Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Jun 25, 2025KYMR
Kymera Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
16K shares- - Jun 11, 2025OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
24.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  KYMR Kymera Therapeutics, Inc. | Award Stock Option (Right to Buy) | 6,068 | - | - | Direct |
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Jun 25, 2025 | KYMR Kymera Therapeutics, Inc. | Award Stock Option (Right to Buy) | 16,000 | - | - | Direct |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 24,150 | - | - | Direct |
1-4 of 4 transactions